rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2001-8-9
|
pubmed:abstractText |
This study was aimed at investigating the diagnostic value of maternal serum C-reactive protein (CRP) in the recognition of chorioamnionitis in patients undergoing fetal reduction.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1058-0468
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
336-40
|
pubmed:dateRevised |
2008-3-18
|
pubmed:meshHeading |
pubmed-meshheading:11495410-C-Reactive Protein,
pubmed-meshheading:11495410-Chorioamnionitis,
pubmed-meshheading:11495410-Female,
pubmed-meshheading:11495410-Follow-Up Studies,
pubmed-meshheading:11495410-Gestational Age,
pubmed-meshheading:11495410-Humans,
pubmed-meshheading:11495410-Placenta,
pubmed-meshheading:11495410-Pregnancy,
pubmed-meshheading:11495410-Pregnancy, Multiple,
pubmed-meshheading:11495410-Pregnancy Reduction, Multifetal
|
pubmed:year |
2001
|
pubmed:articleTitle |
Maternal serum C-reactive protein level does not change significantly after fetal reduction: it could be used as an indicator of chorioamnionitis.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|